Cajanin ( —— )

产品货号. M30929 CAS No. 32884-36-9

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

产品询价大包装询价加入购物车

产品名称

Cajanin
注意事项

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
产品简述

Cajanin has potential hypolipidemic effects,possibly via up-regulating the ABCA1 protein expression,subsequently resulting in increased macrophage cholesterol efflux and RCT, it can significantly improve basal glucose uptake in HepG2 cells, its improving effect is concentration dependent, it exhibits effects stronger than that of rosiglitazone, which has been used as an antidiabetic drug.
产品描述

Cajanin has potential hypolipidemic effects,possibly via up-regulating the ABCA1 protein expression,subsequently resulting in increased macrophage cholesterol efflux and RCT, it can significantly improve basal glucose uptake in HepG2 cells, its improving effect is concentration dependent, it exhibits effects stronger than that of rosiglitazone, which has been used as an antidiabetic drug.
体外实验

Cajanin shows strong mitogenic as well as differentiation-promoting effects on osteoblasts.Cajanin induces the phosphorylation of both Erk1/2 and Akt.
体内实验

Cajanin (10 mg/kg, p.o.; daily for 30 consecutive days) increases the BMD levelsin all anatomical regions of the skeleton studied in Sprague Dawley rats.
同义词

——
通路

Others
靶点

Other Targets
受体

——
研究领域

——
适应症

——

计算器

产品手册

关联产品

L-822179

L-822179 (α5IA) 是 GABAA 受体 A5 亚型的选择性反向激动剂，与其他药物相比，对 A5 亚型具有更高的内在活性。
Kadsuric acid

Standard reference
Pirmenol

Pirmenol 是一种具有口服活性的抗心律失常剂。Pirmenol 通过阻断毒蕈碱性受体 (mAchR) 来抑制 IK.ACh (IC50: 0.1 μM)。可用于心血管疾病的研究，如心房颤动。Pirmenol 通过阻断毒蕈碱性受体 (mAchR) 来抑制 IK.ACh (IC50: 0.1 μM)。